Patents by Inventor James R. Mickelson

James R. Mickelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8268557
    Abstract: The present invention relates to diagnosing Polysaccharide Storage Myopathy (PSSM) disease in equines.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: September 18, 2012
    Inventors: Stephanie J. Valberg, Molly E. McCue, James R. Mickelson
  • Patent number: 8178297
    Abstract: The present invention relates to diagnosing Canine Exercise-Induced Collapse (EIC).
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: May 15, 2012
    Inventors: James R. Mickelson, Katie Minor, Susan M. Taylor, Edward Earl Patterson
  • Publication number: 20100279286
    Abstract: The present invention relates to diagnosing Polysaccharide Storage Myopathy (PSSM) disease in equines.
    Type: Application
    Filed: February 14, 2007
    Publication date: November 4, 2010
    Inventors: Stephanie J. Valberg, Molly E. McCue, James R. Mickelson
  • Publication number: 20100196900
    Abstract: The present invention relates to diagnosing Canine Exercise-Induced Collapse (EIC).
    Type: Application
    Filed: April 8, 2009
    Publication date: August 5, 2010
    Inventors: James R. Mickelson, Katie Minor, Susan M. Taylor, Edward Earl Patterson
  • Publication number: 20090258360
    Abstract: The present invention relates to diagnosing Polysaccharide Storage Myopathy (PSSM) disease in equines.
    Type: Application
    Filed: January 30, 2009
    Publication date: October 15, 2009
    Inventors: Stephanie J. Valberg, Molly E. McCue, James R. Mickelson
  • Patent number: 7129049
    Abstract: The present invention relates to diagnosing glycogen storage diseases in mammals.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: October 31, 2006
    Assignee: Regents of the University of Minnesota
    Inventors: Stephanie J. Valberg, James R. Mickelson
  • Publication number: 20040110217
    Abstract: A method of determining whether a canine is susceptible to canine malignant hyperthermia is disclosed. In one embodiment, this method comprises the step of obtaining a nucleic acid sample from a canine and examining the DNA sample for the presence or absence of a T1640C mutation, wherein the presence of the mutation indicates that the canine is susceptible to canine malignant hyperthermia.
    Type: Application
    Filed: October 21, 2003
    Publication date: June 10, 2004
    Inventors: Kirk J. Hogan, David B. Brunson, Monica C. Roberts, James R. Mickelson
  • Patent number: 6664059
    Abstract: A method of determining whether a canine is susceptible to canine malignant hyperthermia is disclosed. In one embodiment, this method comprises the step of obtaining a nucleic acid sample from a canine and examining the DNA sample for the presence or absence of a T1640C mutation, wherein the presence of the mutation indicates that the canine is susceptible to canine malignant hyperthermia.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: December 16, 2003
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Kirk J. Hogan, David B. Brunson, Monica C. Roberts, James R. Mickelson
  • Publication number: 20030104382
    Abstract: A method of determining whether a canine is susceptible to canine malignant hyperthermia is disclosed. In one embodiment, this method comprises the step of obtaining a nucleic acid sample from a canine and examining the DNA sample for the presence or absence of a T1640C mutation, wherein the presence of the mutation indicates that the canine is susceptible to canine malignant hyperthermia.
    Type: Application
    Filed: July 18, 2001
    Publication date: June 5, 2003
    Inventors: Kirk J. Hogan, David B. Brunson, Monica C. Roberts, James R. Mickelson
  • Patent number: 5462857
    Abstract: The present invention relates to a method of diagnosing malignant hyperthermia susceptibility by detecting abnormal ryanodine receptor fragments following proteolytic enzyme digestion of ryanodine receptors isolated from the sarcoplasmic reticulum of mammalian skeletal muscle. The detection of abnormal ryanodine receptor fragments is indicative of malignant hyperthermia susceptibility.
    Type: Grant
    Filed: August 9, 1993
    Date of Patent: October 31, 1995
    Assignee: University of Iowa Research Foundation
    Inventors: Kevin P. Campbell, C. Michael Knudson, Steven D. Kahl, Charles F. Louis, James R. Mickelson
  • Patent number: 5242801
    Abstract: The present invention relates to a method of diagnosing malignant hyperthermia susceptibility by detecting abnormal ryanodine receptor fragments following proteolytic enzyme digestion of ryanodine receptors isolated from the sarcoplasmic reticulum of mammalian skeletal muscle. The detection of abnormal ryanodine receptor fragments is indicative of malignant hyperthermia susceptibility.
    Type: Grant
    Filed: August 6, 1990
    Date of Patent: September 7, 1993
    Assignees: University of Iowa Research Foundation, Regents of the University of Minnesota
    Inventors: Kevin P. Campbell, C. Michael Knudson, Steven D. Kahl, Charles F. Louis, James R. Mickelson